银屑病关节炎缓解与低疾病活动度报道的系统综述与荟萃分析
仅35.3%的研究报道了REM/LDA,不同定义下汇总患病率差异显著:REM为13.1%至42.1%,LDA为36.3%至60.4%。
要点
- 仅约三分之一银屑病关节炎研究报道缓解或低疾病活动度状态。
- 缓解患病率因定义不同波动于13.1%至42.1%。
- 低疾病活动度患病率因定义不同波动于36.3%至60.4%。
核心结论
- 银屑病关节炎研究中缓解和低疾病活动度的报道率低且定义不一致,亟需共识。
研究设计与样本
- 系统文献综述与随机效应荟萃分析,检索2012至2019年PubMed、EMBASE和Cochrane数据库的英文临床研究。
- 患者平均年龄49.4(4.4)岁,平均病程8.5(3.8)年。
主要发现
- 91/258篇(35.3%)出版物报道了缓解或低疾病活动度。
- 在91篇中,61篇(67.0%)使用VLDA/MDA,27篇(29.6%)使用DAPSA,28篇(30.7%)使用DAS28,40篇(43.9%)报道了多种定义。
- 缓解的汇总患病率:VLDA为13.1%(10.9-15.4),DAPSA-REM为23.1%(16.8-30.1),DAS28为42.1%(33.9-50.4)。
- 低疾病活动度的汇总患病率:MDA为36.3%(32.3-40.5),DAPSA-LDA为52.8%(41.8-63.6),DAS28为60.4%(52.5-68.0)。
关键数值与推荐
- 缓解定义包括VLDA、DAPSA-REM和DAS28缓解。
- 低疾病活动度定义包括MDA、DAPSA-LDA和DAS28低疾病活动度。
临床怎么用
- 临床解读银屑病关节炎缓解率时需注意研究所用定义,不同定义下患病率差异可达数倍。
- 建议在临床研究和实践中推动缓解与低疾病活动度定义的标准化。
局限性
- 仅纳入英文文献,可能存在语言偏倚。
- 不同研究间患者特征和治疗方法差异可能影响汇总患病率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Remission (REM) or low disease activity (LDA) is the treatment target in psoriatic arthritis (PsA). The objective of this study was to assess the reporting and prevalence of REM/LDA in published studies of PsA. METHODS: This was a systematic literature review of all clinical papers published in PubMed, EMBASE or Cochrane database in English between 2012 and 2019 in the field of PsA. Data were collected regarding reporting of REM/LDA by very low disease activity/minimal disease activity (VLDA/MDA), Disease Activity index for Psoriatic Arthritis (DAPSA), or Disease Activity Score 28 joints (DAS28). The pooled rates of REM and LDA by each definition were calculated by random effect meta-analysis. RESULTS: In all, 258 publications (corresponding to 114 651 patients), of which 81 (31%) were randomized controlled trials, were analysed: patients' mean age was 49.4 ( 4.4) years; with a mean disease duration of 8.5 ( 3.8) years. REM/LDA was reported in 91/258 (35.3%) publications. VLDA/MDA was used in 61/91 (67.0%) studies, DAPSA in 27/91 (29.6%) and DAS28 in 28/91 (30.7%), with 40/91 (43.9%) papers reporting several of these definitions. The pooled prevalence (lower-upper limits) of REM was 13.1% (10.9-15.4), 23.1% (16.8-30.1) and 42.1% (33.9-50.4) using VLDA, DAPSA-REM and DAS28, respectively. For LDA the pooled prevalence was 36.3% (32.3-40.5), 52.8% (41.8-63.6) and 60.4% (52.5-68.0) using MDA, DAPSA-LDA and DAS28, respectively. CONCLUSION: REM/LDA status was reported in only1/3 of recent studies on PsA, with important variations in the frequency of these outcomes according to the definition used: 13.1-42.1% for REM, and 36.3-60.4% for LDA. This highlights the need for consensus.
引用
- Hagège B, Tan E, Gayraud M, et al. Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis. Rheumatology (Oxford). 2020. PMID: 32118267. doi:10.1093/rheumatology/keaa030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。